Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



crescenteric glomerulonephritis1 - metastatic prostate cancer5 - uterine prolapse4 - recurrent urinary tract infections1 - urinary tract dysfunction1 - end-stage renal failure1 - alpha blockers1 - kidney tissue2 - plco trial1 - optn1 - local recurrence1 - prostate treatment system1 - renal cancer2 - hypoxia1 - autoimmune disease2 - mount sinai1 - uti7 - stone formation3 - erythrocyte casts1 - hormone replacement1 - anemia1 - differential diagnosis1 - dialysis center1 - urinary arsenic1 - autosomal-dominant polycystic kidney disease2 - ureteral calculi1 - henry ford hospital1 - recurrent kidney stones1 - hormone-refractory prostate cancer2 - esrd6 -